Blood Vessels, Thrombosis & Hemostasis
Издатель: Elsevier · ISSN 2950-3272 · 72 статей
- Temporal activation of the contact coagulation pathway after endovascular treatments for acute ischemic stroke
- P-Selectin Inhibition Prevents Trauma-Induced Systemic Microvascular Obstruction in a Murine Model of Polytrauma
- Defibrotide inhibits thrombin-dependent functions only at supratherapeutic concentrations
- Thromborepair: the tissue repair partner to thromboinflammation
- Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
- Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases
- The 2025 McMaster Immune Thrombocytopenia (ITP) Summit: insights from autoimmune hemolytic anemia
- Targeting plasma cells for treatment of immune thrombocytopenia
- Bruton’s tyrosine kinase inhibitors in primary immune thrombocytopenia: pathophysiology and clinical evidence
- The molecular pathophysiology of immune thrombocytopenia: the new frontier
- Low platelets, high stakes: pregnancy after a diagnosis of immune thrombocytopenia
- Indium-labeled scintigraphy to predict splenectomy response in ITP: back to the future
- The role of anti–factor Xa in patients with cancer receiving prophylactic low-molecular-weight heparin: a meta-analysis
- Beyond thrombosis: a scoping review of patient-reported outcomes in antiphospholipid syndrome
- Real-world thrombotic and survival outcomes with ESAs in cancer-related anemia
- Decoding full-length factor VIII through the structural and functional lens of its B domain
- Seconds-resolved in vivo measurements reveal rapid, serotonin transporter–independent plasma serotonin clearance
- Phosphorylation of tyrosine 519 and 520 on Syk is essential for ITAM and hemITAM signaling and function in platelets
- Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A
- Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A
- Interindividual variability in platelet aggregation among aspirin-treated patients: a large retrospective analysis
- An iPSC model of thrombocytopenia-absent radius syndrome links aberrant splicing to impaired megakaryopoiesis
- Clinical and economic impact of rFVIIa prophylaxis in Glanzmann thrombasthenia: cohort analysis in Saudi Arabia
- Endothelial indoleamine 2,3-dioxygenase 1 drives high-tryptophan diet–mediated thrombosis in cancer-bearing mice
- Thromboinflammation and immunothrombosis drive lung pathology after bacterial and viral infection
- Platelets mediate fibrin-induced thromboinflammation and NETosis through a GPVI-polyphosphate-FXIIa procoagulant axis
- Thromboembolic and hemorrhagic risks after mastectomy with vs without direct-to-implant reconstruction
- Antineoplastic therapies associated with venous thromboembolism: disproportionality analysis of the WHO database
- Safety and effectiveness of caplacizumab in pediatric patients with iTTP: real-world experience
- Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis